Make scientific figures in minutes
Create publication-quality figures with pre-made icons and templates, all from BioRender's web-based software
Use Icons In The App
Try a synonym, or sign up to request an icon from the app.
Generic enzyme 6a
[{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce01ef02f730400c4f8c0/5d2cdf64f02f730400c4f896.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce01ef02f730400c4f8c0/5d2cdf64f02f730400c4f896.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce01ef02f730400c4f8bf/5d2cdf64f02f730400c4f896.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce01ef02f730400c4f8bf/5d2cdf64f02f730400c4f896.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce01ef02f730400c4f8be/5d2cdf64f02f730400c4f896.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce01ef02f730400c4f8be/5d2cdf64f02f730400c4f896.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce01ef02f730400c4f8bd/5d2cdf64f02f730400c4f896.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce01ef02f730400c4f8bd/5d2cdf64f02f730400c4f896.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce01ef02f730400c4f8bc/5d2cdf64f02f730400c4f896.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce01ef02f730400c4f8bc/5d2cdf64f02f730400c4f896.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce01ef02f730400c4f8bb/5d2cdf64f02f730400c4f896.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce01ef02f730400c4f8bb/5d2cdf64f02f730400c4f896.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce01ef02f730400c4f8ba/5d2cdf64f02f730400c4f896.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce01ef02f730400c4f8ba/5d2cdf64f02f730400c4f896.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce01ef02f730400c4f8b9/5d2cdf64f02f730400c4f896.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce01ef02f730400c4f8b9/5d2cdf64f02f730400c4f896.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce01ef02f730400c4f8b8/5d2cdf64f02f730400c4f896.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce01ef02f730400c4f8b8/5d2cdf64f02f730400c4f896.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce01ef02f730400c4f8b7/5d2cdf64f02f730400c4f896.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce01ef02f730400c4f8b7/5d2cdf64f02f730400c4f896.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce01ef02f730400c4f8b6/5d2cdf64f02f730400c4f896.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce01ef02f730400c4f8b6/5d2cdf64f02f730400c4f896.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce01ef02f730400c4f8b5/5d2cdf64f02f730400c4f896.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce01ef02f730400c4f8b5/5d2cdf64f02f730400c4f896.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce01ef02f730400c4f8b4/5d2cdf64f02f730400c4f896.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce01ef02f730400c4f8b4/5d2cdf64f02f730400c4f896.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce01ef02f730400c4f8b3/5d2cdf64f02f730400c4f896.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce01ef02f730400c4f8b3/5d2cdf64f02f730400c4f896.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce01ef02f730400c4f8b2/5d2cdf64f02f730400c4f896.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce01ef02f730400c4f8b2/5d2cdf64f02f730400c4f896.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce01ef02f730400c4f8b1/5d2cdf64f02f730400c4f896.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce01ef02f730400c4f8b1/5d2cdf64f02f730400c4f896.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce01ef02f730400c4f8b0/5d2cdf64f02f730400c4f896.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce01ef02f730400c4f8b0/5d2cdf64f02f730400c4f896.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce01ef02f730400c4f8af/5d2cdf64f02f730400c4f896.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce01ef02f730400c4f8af/5d2cdf64f02f730400c4f896.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce01ef02f730400c4f8ae/5d2cdf64f02f730400c4f896.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce01ef02f730400c4f8ae/5d2cdf64f02f730400c4f896.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce01ef02f730400c4f8ad/5d2cdf64f02f730400c4f896.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce01ef02f730400c4f8ad/5d2cdf64f02f730400c4f896.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce01ef02f730400c4f8ac/5d2cdf64f02f730400c4f896.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce01ef02f730400c4f8ac/5d2cdf64f02f730400c4f896.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce01ef02f730400c4f8ab/5d2cdf64f02f730400c4f896.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce01ef02f730400c4f8ab/5d2cdf64f02f730400c4f896.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce01ef02f730400c4f8aa/5d2cdf64f02f730400c4f896.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce01ef02f730400c4f8aa/5d2cdf64f02f730400c4f896.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce01ef02f730400c4f8a9/5d2cdf64f02f730400c4f896.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce01ef02f730400c4f8a9/5d2cdf64f02f730400c4f896.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce01ef02f730400c4f8a8/5d2cdf64f02f730400c4f896.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce01ef02f730400c4f8a8/5d2cdf64f02f730400c4f896.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce01ef02f730400c4f8a7/5d2cdf64f02f730400c4f896.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce01ef02f730400c4f8a7/5d2cdf64f02f730400c4f896.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce01ef02f730400c4f8a6/5d2cdf64f02f730400c4f896.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce01ef02f730400c4f8a6/5d2cdf64f02f730400c4f896.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce01ef02f730400c4f8a5/5d2cdf64f02f730400c4f896.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce01ef02f730400c4f8a5/5d2cdf64f02f730400c4f896.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce01ef02f730400c4f8a4/5d2cdf64f02f730400c4f896.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce01ef02f730400c4f8a4/5d2cdf64f02f730400c4f896.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce01ef02f730400c4f8a3/5d2cdf64f02f730400c4f896.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce01ef02f730400c4f8a3/5d2cdf64f02f730400c4f896.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce01ef02f730400c4f8a2/5d2cdf64f02f730400c4f896.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce01ef02f730400c4f8a2/5d2cdf64f02f730400c4f896.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce01ef02f730400c4f8a1/5d2cdf64f02f730400c4f896.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce01ef02f730400c4f8a1/5d2cdf64f02f730400c4f896.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce01ef02f730400c4f8a0/5d2cdf64f02f730400c4f896.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce01ef02f730400c4f8a0/5d2cdf64f02f730400c4f896.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce01ef02f730400c4f89f/5d2cdf64f02f730400c4f896.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce01ef02f730400c4f89f/5d2cdf64f02f730400c4f896.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce01ef02f730400c4f89e/5d2cdf64f02f730400c4f896.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce01ef02f730400c4f89e/5d2cdf64f02f730400c4f896.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce01ef02f730400c4f89d/5d2cdf64f02f730400c4f896.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce01ef02f730400c4f89d/5d2cdf64f02f730400c4f896.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce01ef02f730400c4f89c/5d2cdf64f02f730400c4f896.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce01ef02f730400c4f89c/5d2cdf64f02f730400c4f896.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce01ef02f730400c4f89b/5d2cdf64f02f730400c4f896.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce01ef02f730400c4f89b/5d2cdf64f02f730400c4f896.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce01ef02f730400c4f89a/5d2cdf64f02f730400c4f896.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce01ef02f730400c4f89a/5d2cdf64f02f730400c4f896.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce01ef02f730400c4f899/5d2cdf64f02f730400c4f896.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce01ef02f730400c4f899/5d2cdf64f02f730400c4f896.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce01ef02f730400c4f898/5d2cdf64f02f730400c4f896.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce01ef02f730400c4f898/5d2cdf64f02f730400c4f896.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce01ef02f730400c4f897/5d2cdf64f02f730400c4f896.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce01ef02f730400c4f897/5d2cdf64f02f730400c4f896.png"}]
Use this icon in BioRender along with 1000s of others to make your next science figure in minutes
SIGN UP FREEKeywords
receptor,ligand,target ligand,targeting ligand,targeted ligand,protein,pathway,signaling,cascade,diagram,transcription factor,generic,catalyst,enzyme,substrate,lock and key
Image types
BioRender icons and templates meet journal, grant, and copyright standards. For AI-generated figures, policies vary. Learn More
Join 1,500,000 other scientists on BioRender
Sign up for your free account and start creating scientific figures faster today
FAQs
What is BioRender?
Can I use this icon in a BioRender figure or scientific illustration?
